RxDoctor Payments Data
★ My doctorsLook up a doctor →

Jose Wiley, MD

Interventional Cardiology · New Orleans, LANPI 1366542284

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (59.2%), charitable contributions and travel and lodging — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Biotronik Inc. at 32.1% of the total. Reporting peaked in 2021 at $14,239 and has fallen 78.9% since, to $3,005 in 2025.

$33,591in general payments, 2019–2025

Across 241 payments — averaging $139.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biotronik Inc.$11K
  • Medtronic$5K
  • Abbott$4K
  • Edwards Lifesciences$2K
  • Abiomed$2K
  • Boston Scientific$2K
  • plus $8K from 28 others
$65,493in research payments, 2019–2025

Across 14 payments — averaging $4678.07 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Philips North America LLC$35K
  • Bard Peripheral Vascular, Inc.$30K

What the payments were for

  • Travel & lodging$3,71711%
  • Food & beverage$19,87459%
  • Charitable contribution$10,00030%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Biotronik Inc.9$10,788
Medtronic(2 entities)48$4,574
Abbott31$4,226
Edwards Lifesciences21$2,175
Abiomed22$1,923
Boston Scientific14$1,502
Cardiovascular Systems Inc.22$1,190
Philips North America LLC11$1,056
Omega Medical Imaging, LLC1$724
Avinger Inc.6$704
Angiodynamics, Inc.7$630
Cook Medical LLC5$588
Amgen8$482
Scpharmaceuticals Inc.3$432
Shockwave Medical, Inc3$309
Esperion Therapeutics, Inc.2$273
E.r. Squibb & Sons, L.L.C.2$246
Spectrawave, Inc1$237
Biosense Webster, Inc.2$198
Venturemed Group, Inc.2$164
Livanova USA, Inc.2$136
AstraZeneca1$122
Bard Peripheral Vascular, Inc.1$120
W. L. Gore & Associates, Inc.2$115
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)5$114
Stryker2$102
Siemens Medical Solutions USA, Inc.1$96
Saranas, Inc.1$81
Cardiva Medical, Inc.1$72
Terumo Medical Corporation1$66
Acist Medical Systems, Inc.1$49
Actelion Pharmaceuticals US, Inc.1$39
Cardinal Health 200 LLC1$36
Penumbra, Inc.1$23

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$33,591 in reported general payments places this provider in the 80th percentile of 171 interventional cardiology providers in Louisiana.

See all interventional cardiology providers in Louisiana →

Medicare billing

Part B allowed, 2024
$4,393
Medicare patients
11
Services billed
28

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in New Orleans

See the full list for Louisiana →

Where these figures come from

Is this you, or does something look wrong? →